Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter
Reported by FDA recalls · November 6 at 6:00 AM · Summary by Whisk & Kettle

Eugia US LLC of East Windsor, New Jersey, is voluntarily recalling lot 3VM26026A of Vancomycin Hydrochloride for Injection, 1.25 g per 30 mL single-dose vial, to the hospital and healthcare user level. A glass particle was found inside the vial. The lot shipped to wholesalers nationwide from September 2 to September 15, 2026.
Background
Glass particles in injectable drugs can lodge in blood vessels and cause clots or irritation, which is why the FDA treats them seriously. Recalls at the hospital or user level usually mean the product went to clinical settings rather than retail shelves, and recall notices typically ask holders to quarantine and return affected stock.
Why it matters
Even though this vial is a hospital antibiotic, it shows how a single manufacturing defect can reach care settings, and why recall notices are worth checking.
What you can do
If you are a patient or caregiver with questions, ask your physician or pharmacist whether any medicine you receive comes from this lot. Anyone holding this lot should contact the manufacturer or their supplier about return.
Written by Whisk & Kettle from the report by FDA recalls. Background is general information, not advice about your piece of kitchenware; if you are worried, call your vet.
For dogs
Made in the USA
Made in the USA
Made in the USA

